Model
Edge
Halozyme Therapeutics, Inc.
0001910662
Filing Type
4
Filing Date
2/17/2025
Updated
2/18/25, 4:39 PM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership